152 related articles for article (PubMed ID: 29472141)
1. T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathy.
Pavlovic D; Patel MA; Patera AC; Peterson I;
Immunobiology; 2018; 223(6-7):508-517. PubMed ID: 29472141
[TBL] [Abstract][Full Text] [Related]
2. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
3. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
Khalili A; Craigie M; Donadoni M; Sariyer IK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
[TBL] [Abstract][Full Text] [Related]
4. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
[TBL] [Abstract][Full Text] [Related]
5. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
Koralnik IJ
J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
[TBL] [Abstract][Full Text] [Related]
6. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
[TBL] [Abstract][Full Text] [Related]
7. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik IJ; Du Pasquier RA; Letvin NL
J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
[TBL] [Abstract][Full Text] [Related]
8. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.
Gheuens S; Bord E; Kesari S; Simpson DM; Gandhi RT; Clifford DB; Berger JR; Ngo L; Koralnik IJ
J Virol; 2011 Jul; 85(14):7256-63. PubMed ID: 21543472
[TBL] [Abstract][Full Text] [Related]
9. Immunology of progressive multifocal leukoencephalopathy.
Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
Jelcic I; Jelcic I; Kempf C; Largey F; Planas R; Schippling S; Budka H; Sospedra M; Martin R
Ann Neurol; 2016 Mar; 79(3):404-18. PubMed ID: 26874214
[TBL] [Abstract][Full Text] [Related]
11. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
[TBL] [Abstract][Full Text] [Related]
12. Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.
O'Neill FJ; Greenlee JE; Dörries K; Clawson SA; Carney H
J Neurovirol; 2003 Oct; 9(5):567-76. PubMed ID: 13129771
[TBL] [Abstract][Full Text] [Related]
13. John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy.
Pietropaolo V; Prezioso C; Bagnato F; Antonelli G
New Microbiol; 2018 Jul; 41(3):179-186. PubMed ID: 29620790
[TBL] [Abstract][Full Text] [Related]
14. Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy.
Marzocchetti A; Lima M; Tompkins T; Kavanagh DG; Gandhi RT; O'Neill DW; Bhardwaj N; Koralnik IJ
Virology; 2009 Jan; 383(2):173-7. PubMed ID: 19062062
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of progressive multifocal leukoencephalopathy: a practical approach.
Bartsch T; Rempe T; Leypoldt F; Riedel C; Jansen O; Berg D; Deuschl G
Eur J Neurol; 2019 Apr; 26(4):566-e41. PubMed ID: 30629326
[TBL] [Abstract][Full Text] [Related]
16. Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.
Hadjadj J; Guffroy A; Delavaud C; Taieb G; Meyts I; Fresard A; Streichenberger N; L'Honneur AS; Rozenberg F; D'Aveni M; Aguilar C; Rosain J; Picard C; Mahlaoui N; Lecuit M; Hermine O; Lortholary O; Suarez F
J Clin Immunol; 2019 Jan; 39(1):55-64. PubMed ID: 30552536
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of progressive multifocal leukoencephalopathy--revisited.
White MK; Khalili K
J Infect Dis; 2011 Mar; 203(5):578-86. PubMed ID: 21227915
[TBL] [Abstract][Full Text] [Related]
18. [Role of immunity in the development of progressive multifocal leukoencephalopathy: a report of three patients with type B lymphoma and humoral immunodeficiency and six others with acquired immunodeficiency syndrome].
Malkoun I; Vidry E; Revenco E; Drobacheff MC; Berger E; Rumbach L
Rev Neurol (Paris); 2006 Jan; 162(1):82-8. PubMed ID: 16446626
[TBL] [Abstract][Full Text] [Related]
19. The Progressive Multifocal Leukoencephalopathy Consortium as a Model for Advancing Research and Dialogue on Rare Severe Adverse Drug Reactions.
Peterson IS; Iverson WO; Kasaian MT; Liu M
Adv Ther; 2019 Apr; 36(4):757-765. PubMed ID: 30758742
[TBL] [Abstract][Full Text] [Related]
20. Progressive multifocal leukoencephalopathy: why gray and white matter.
Gheuens S; Wüthrich C; Koralnik IJ
Annu Rev Pathol; 2013 Jan; 8():189-215. PubMed ID: 23092189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
